Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4475
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis or “the company”) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. Ionis is headquartered in Carlsbad, California, the US.

Scope

- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Ionis Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ionis Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Ionis Pharmaceuticals, Inc.: Company Overview 9
Ionis Pharmaceuticals, Inc.: Overview and Key Facts 9
Ionis Pharmaceuticals, Inc.: Overview 9
Ionis Pharmaceuticals, Inc.: Key Facts 9
Ionis Pharmaceuticals, Inc.: Key Employees 11
Ionis Pharmaceuticals, Inc.: Key Employee Biographies 12
Ionis Pharmaceuticals, Inc.: Major Products and Services 15
Ionis Pharmaceuticals, Inc.: Company History 16
Ionis Pharmaceuticals, Inc.: Management Statement 21
Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries 24
Ionis Pharmaceuticals, Inc.: Key Competitors 25
Ionis Pharmaceuticals, Inc.: Company Analysis 26
Ionis Pharmaceuticals, Inc.: Business Description 26
Ionis Pharmaceuticals, Inc.: SWOT Analysis 27
Ionis Pharmaceuticals, Inc.: SWOT Overview 27
Ionis Pharmaceuticals, Inc.: Strengths 27
Ionis Pharmaceuticals, Inc.: Weaknesses 28
Ionis Pharmaceuticals, Inc.: Opportunities 28
Ionis Pharmaceuticals, Inc.: Threats 29
Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity 31
Ionis Pharmaceuticals, Inc.: Financial Deals Overview 31
Ionis Pharmaceuticals, Inc.: Targets and Partners 33
Ionis Pharmaceuticals, Inc.: Top Deals 2014 – 2018YTD* 35
Ionis Pharmaceuticals, Inc.: Advisors 36
Ionis Pharmaceuticals, Inc.: Top Legal Advisors 36
Ionis Pharmaceuticals, Inc.: Top Financial Advisors 36
Ionis Pharmaceuticals, Inc.: Corporate Venturing 37
Ionis Pharmaceuticals, Inc.: Capital Raising 38
Ionis Pharmaceuticals, Inc.: Partnership 39
Ionis Pharmaceuticals, Inc.: Divestments 40
Ionis Pharmaceuticals, Inc.: Private Equity and Ownership 41
Ionis Pharmaceuticals, Inc.: Recent Developments 42
Ionis Pharmaceuticals, Inc.: News and Events Summary 42
Ionis Pharmaceuticals, Inc.: Corporate Governance 45
Ionis Pharmaceuticals, Inc.: Financial Performance 46
Ionis Pharmaceuticals, Inc.: Market Developments 46
Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events 48
Ionis Pharmaceuticals, Inc.: Strategy and Operations 49
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors
Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners
Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2014 - 2018YTD*
Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 19: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Ionis Pharmaceuticals, Inc.: News and Events Summary
Table 22: Ionis Pharmaceuticals, Inc.: Corporate Governance
Table 23: Ionis Pharmaceuticals, Inc.: Financial Performance
Table 24: Ionis Pharmaceuticals, Inc.: Market Developments
Table 25: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 26: Ionis Pharmaceuticals, Inc.: Strategy and Operations

List of Figures
Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 4: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 5: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014 - YTD*2018)
Figure 11: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Alarko Contracting Group:企業の戦略・SWOT・財務分析
    Alarko Contracting Group - Strategy, SWOT and Corporate Finance Report Summary Alarko Contracting Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Chr. Hansen Holding AS (CHR):製薬・医療:M&Aディール及び事業提携情報
    Summary Chr. Hansen Holding A/S (Chr. Hansen) is a bioscience company that focuses on the development of natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries. The company develops, produces and markets cultures, enzymes, probiotics and natural colors. It …
  • Landesbank Berlin Holding Ag
    Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report Summary Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Ambu AS (AMBU B):製品パイプライン分析
    Summary Ambu A/S (Ambu) is a medical device company with a focus on anesthesia, patient monitoring and diagnostics and emergency care markets. It manufactures and markets life supporting devices, catering to hospitals, clinics, sleep laboratories and rescue services. The major products of the compan …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NOJA Power Switchgear Pty Ltd:企業の戦略的SWOT分析
    NOJA Power Switchgear Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Hanwha Chemical Corp (009830):企業の財務・戦略的SWOT分析
    Summary Hanwha Chemical Corp (Hanwha), a subsidiary of Hanwha Corp is a chemical company that manufactures, develops, and distributes basic industrial chemicals, general purpose plastic products, and other chemical products. The company's chemical products include inorganic compounds, PVC, polymers, …
  • Rosinter Restaurants Holding Ojsc:企業の戦略・SWOT・財務分析
    Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report Summary Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PDL BioPharma Inc (PDLI)-製薬・医療分野:企業M&A・提携分析
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). …
  • Vestas Wind Systems A/S:企業の戦略・SWOT・財務分析
    Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report Summary Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • WEC Energy Group Inc (WEC)-エネルギー分野:企業M&A・提携分析
    Summary WEC Energy Group, Inc. (WEC) is a diversified holding company that carries out the generation and distribution of electricity in southeastern Wisconsin, east central Wisconsin, northern Wisconsin, and Michigan's Upper Peninsula; and transports and distributes natural gas in the upper peninsu …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hewlett Packard Enterprise Company:戦略・SWOT・企業財務分析
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Norgine BV:医療機器:M&Aディール及び事業提携情報
    Summary Norgine BV (Norgine) is a pharmaceutical company that offers medicinal products. The company develops drugs in the therapeutic areas of gastroenterology, incontinence, hepatology and critical and supportive care and pain management, among others. It offers the treatment of diseases related t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆